The inside story of a disgraced drugmaker
FT News Briefing
00:00
The Rise and Fall of a Controversial Fentanyl Drugmaker
This chapter explores the rise of a pharmaceutical company notorious for its fentanyl product, originally aimed at helping cancer patients. It contrasts the founder's intentions with the unethical practices that fueled the opioid epidemic, shedding light on the company's significant influence despite entering the market late.
Transcript
Play full episode
